ARGXArgen X SE
Slide 1 of 3
Company Overview
Name
Argen X SE
52W High
$934.13
52W Low
$510.06
Market Cap
$55.6B
Dividend Yield
0%
Price/earnings
13.92
P/E
13.92
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$2.2B
Operating Revenue
$2.2B
Total Gross Profit
$2B
Total Operating Income
$-66.6M
Net Income
$833M
EV to EBITDA
$0.00
EV to Revenue
$27.30
Price to Book value
$0.00
Price to Earnings
$66.71
Additional Data
Selling, General & Admin Expense
$1.1B
Research & Development Expense
$1B
Total Operating Expenses
$-2B
Interest & Investment Income
$157.5M
Other Income / (Expense), net
$-7.6M
Total Other Income / (Expense), net
$149.9M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Argen X SE
52W High
$934.13
52W Low
$510.06
Market Cap
$55.6B
Dividend Yield
0%
Price/earnings
13.92
P/E
13.92
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$2.2B
Operating Revenue
$2.2B
Total Gross Profit
$2B
Total Operating Income
$-66.6M
Net Income
$833M
EV to EBITDA
$0.00
EV to Revenue
$27.30
Price to Book value
$0.00
Price to Earnings
$66.71
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$1.1B
Research & Development Expense
$1B
Total Operating Expenses
$-2B
Interest & Investment Income
$157.5M
Other Income / (Expense), net
$-7.6M
Total Other Income / (Expense), net
$149.9M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Tim v. Hauwermeiren
Location
N/A, Belgium
Exchange
Nasdaq
Website
https://argenx.com
Summary
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases.
Company Info
CEO
Tim v. Hauwermeiren
Location
N/A, Belgium
Exchange
Nasdaq
Website
https://argenx.com
Summary
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases.
